About Paragard
Paragard is a company based in North Wales (United States) founded in 1997 was acquired by CooperSurgical in September 2017. It operates as a Direct-to-Consumer (D2C). Paragard offers products and services including Paragard IUD. Paragard operates in a competitive market with competitors including Daré Bioscience, Aspivix, Femasys, Adiana and Famy Care, among others.
- Headquarter North Wales, United States
- SectorsHealthcare
- Phone•••• ••••
- Website paragard.com
- Social Facebook Instagram YouTube
- Acquired by CooperSurgical (Sep 2017)
- Legal Name Coopersurgical, Inc.
- Investors
- Acquired byCooperSurgical
(Sep 2017)
Products & Services of Paragard
Paragard offers a comprehensive portfolio of products and services, including Paragard IUD.
A hormone-free intrauterine device preventing pregnancy using copper.
Apps and channels of Paragard
its YouTube channel Paragard® (intrauterine copper contraceptive) has 1.29K subscribers and 6 videos.
Videos from Paragard
The most watched videos on Paragard's YouTube channel, Paragard® (intrauterine copper contraceptive) (1.29K subscribers). Click a video to play it here.
Investors in Paragard
Paragard has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CooperSurgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers medical devices for fertility, contraception, and women's health care globally. | 1990 | coopersurgical.com | Trumbull, United States |
Investor details for Paragard
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Paragard
2 people are tracked at Paragard (2 in leadership).
| Name | Role | Group |
|---|---|---|
Kare Schultz | Co-CEO | Leadership |
Paul L. Remmell | Co-CEO & President | Leadership |
Complete people profiles for Paragard
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Paragard
2 dated milestones of Paragard across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Paragard is founded.
- Exit Acquired by CooperSurgical.
Competitors of Paragard
Paragard operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Daré Bioscience, Aspivix, Femasys, Adiana and Famy Care, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| darebioscience.com | 2005 | San Diego, United States | – | 30 | Non-hormonal pharmaceutical products for female contraceptives are developed. | |
| aspivix.com | 2015 | Lausanne, Switzerland | $7.01M | – | A next-generation suction-based cervical device for gynecology is provided. | |
| femasys.com | 2004 | Atlanta, United States | $69.22M | 25 | Medical devices for women's healthcare are developed and provided. | |
| adiana.com | 1997 | Marlborough, United States | $23M | – | Transcervical sterilization systems for permanent birth control are developed. | |
| famycare.com | 1990 | Mumbai, India | $40M | 22 | Suite of women's health products like contraceptives, intrauterine devices, tubal rings and hormone-replacement therapy products | |
| removaid.com | 2012 | Oslo, Norway | – | 5 | Medical devices for subdermal implant removal are developed. | |
| uteron.com | 2002 | Liege, Belgium | $31.09M | – | Develops products dedicated to female healthcare solutions. |
Detailed competitors of Paragard
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Paragard
The website of Paragard (paragard.com) receives about 89.2K visits a month.
- Monthly visits89.2K
▼ 28.1% vs previous month
Websites whose visitors overlap most with Paragard. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bedsider.org | 100% | – | #309,777 | View details | |
nuvaring.com | nuvaring.com | 98% | – | #1,213,931 | – |
nexplanon.com | nexplanon.com | 93% | – | #366,569 | – |
| acog.org | 78% | 1.2M | #57,547 | View details | |
| mirena-us.com | 78% | – | #364,687 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 30 similar websites and full traffic analytics for Paragard
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 30 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Paragard
Complete news archive for Paragard
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Paragard
10 companies that operate in the same segment as Paragard (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 124.07 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 47 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Paragard
Paragard was founded in 1997.
Paragard is headquartered in North Wales, United States. It is registered at North Wales, Pennsylvania, United States.
Kare Schultz is the current CEO of Paragard.
Paragard is known for offering a hormone-free intrauterine device (IUD) that prevents pregnancy for up to 10 years using copper as its active ingredient. The product is positioned in the healthcare sector, specifically targeting women seeking non-hormonal birth control solutions. It is supported by over 30 years of FDA approval and is noted for being over 99 effective. Placement and removal are handled by healthcare providers during routine visits, and cost coverage is often available through insurance plans in the United States.
Paragard's top competitors include Daré Bioscience, Femasys and Famy Care.
Paragard offers Paragard IUD.
Paragard has 1 investor. Key investors include CooperSurgical.
Paragard operates through Coopersurgical, Inc..
Yes. Paragard was acquired by CooperSurgical in September 2017.